InvestorsHub Logo

farrell90

03/16/18 2:24 PM

#221298 RE: DaubersUP #221293

I agree IPIX did a much better job of explaining how the sachets will work and why they are important.

IMO the Brilacidin in the sachets when mixed with liquid could deliver Brilacidin at the same dose as given in the FDA trial. Which is important because the FDA could approve the sachets without an additional clinical trial.

We will have to wait and see.

Scored some more shares this AM at 54.5 cents.New stink bids in place.

Good luck, Farrell

frrol

03/16/18 2:40 PM

#221304 RE: DaubersUP #221293

The sachet is of course not news and any BP discussions of B-OM will have already included these plans. And see my post on sachet feasibility. But yes if the sachet is feasible and if B-OM results looks good to BP then they will be interested. Probably already are and just a matter of mutually agreeable partnership terms.

I've said before, I suspect terms are the sticking point. Everything, from a great B-OM therapy to an OK one has a price.